Allergan posts quarterly profit; migraine treatment succeeds key study

(Reuters) - Allergan Plc posted a quarterly profit, compared with a year-ago loss, due to recent changes in the U.S. tax laws, and the botox maker said its migraine treatment met the main goals in a late-stage study.

Allergan posts quarterly profit; migraine treatment succeeds key study
Read More


Bagikan Berita Ini